These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 26370852)
1. Myocardial Injury after Percutaneous Coronary Intervention for In-Stent Restenosis Versus de novo Stenosis. Shimonaga T; Kurisu S; Watanabe N; Ikenaga H; Higaki T; Iwasaki T; Ishibashi K; Dohi Y; Fukuda Y; Kihara Y Intern Med; 2015; 54(18):2299-305. PubMed ID: 26370852 [TBL] [Abstract][Full Text] [Related]
2. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging. Kang SJ; Cho YR; Park GM; Ahn JM; Han SB; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ JACC Cardiovasc Imaging; 2013 Nov; 6(11):1183-90. PubMed ID: 24229771 [TBL] [Abstract][Full Text] [Related]
3. In-Stent Restenosis of Drug-Eluting Stents Compared With a Matched Group of Patients With De Novo Coronary Artery Stenosis. Buchanan KD; Torguson R; Rogers T; Xu L; Gai J; Ben-Dor I; Suddath WO; Satler LF; Waksman R Am J Cardiol; 2018 Jun; 121(12):1512-1518. PubMed ID: 29627111 [TBL] [Abstract][Full Text] [Related]
4. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience. Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis. Almalla M; Pross V; Marx N; Hoffmann R Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414 [TBL] [Abstract][Full Text] [Related]
6. Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis. Nano N; Aytekin A; Ndrepepa G; Seguchi M; Bresha J; Alvarez Covarrubias HA; Nicol P; Lenz T; Lahu S; Gewalt S; Voll F; Rheude T; Wiebe J; Schunkert H; Kufner S; Cassese S; Joner M; Kastrati A; Xhepa E Clin Res Cardiol; 2022 Jul; 111(7):827-837. PubMed ID: 35476138 [TBL] [Abstract][Full Text] [Related]
7. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A; JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416 [TBL] [Abstract][Full Text] [Related]
8. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do. Wang P; Qiao H; Wang R; Hou R; Guo J BMC Cardiovasc Disord; 2020 Dec; 20(1):510. PubMed ID: 33276720 [TBL] [Abstract][Full Text] [Related]
9. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study. Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795 [TBL] [Abstract][Full Text] [Related]
14. Is a bare-metal stent still useful for improving the outcome of percutaneous coronary intervention? From the FU-Registry. Gondo K; Ike A; Ogawa M; Shirai K; Sugihara M; Nishikawa H; Iwata A; Kawamura A; Mori K; Zhang B; Miura S; Yasunaga S; Saku K J Cardiol; 2017 Apr; 69(4):652-659. PubMed ID: 27492658 [TBL] [Abstract][Full Text] [Related]
15. Impact of optical coherence tomography- and coronary angioscopy-assessed neointimal tissue characteristics on occurrence of periprocedural myonecrosis in patients with in-stent restenosis. Kimura S; Sugiyama T; Hishikari K; Nakamura S; Nakagama S; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Sagawa Y; Kojima K; Ohtani H; Hikita H; Takahashi A; Isobe M Int J Cardiovasc Imaging; 2016 Oct; 32(10):1483-94. PubMed ID: 27423209 [TBL] [Abstract][Full Text] [Related]
16. Periprocedural myocardial damage during percutaneous coronary intervention: a point-of-care platelet testing and intravascular ultrasound/virtual histology study. Michalak M; Huczek Z; Filipiak KJ; Roik MF; Kochman J; Opolski G Kardiol Pol; 2013; 71(4):325-33. PubMed ID: 23788337 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry. Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G; EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062 [TBL] [Abstract][Full Text] [Related]
18. Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up. Cheng G; Chang FJ; Wang Y; You PH; Chen HC; Han WQ; Wang JW; Zhong NE; Min ZQ Med Sci Monit; 2019 Jan; 25():240-247. PubMed ID: 30617247 [TBL] [Abstract][Full Text] [Related]
19. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis. Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y Catheter Cardiovasc Interv; 2015 Mar; 85(4):564-72. PubMed ID: 25158217 [TBL] [Abstract][Full Text] [Related]
20. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials. Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C; Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]